Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
12don MSN
This Unstoppable Cathie Wood ETF Is Obliterating the S&P 500 This Year. Is It a Buy Ahead of 2026?
Cathie Wood is one of the most vocal bulls on Wall Street when it comes to the potential of innovative technologies.
TipRanks on MSN
Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks
Ace hedge fund manager Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several notable trades for Wednesday, ...
TipRanks on MSN
Cathie Wood Continues to Offload Roku and Tempus AI Stocks
Ace hedge fund manager Cathie Wood’s ARK Invest ETFs (exchange-traded funds) have been offloading shares of Roku (ROKU) and ...
What you need to know about Ark Invest, an active ETF firm led by Cathie Wood that invests in disruptive, high-growth tech ...
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) hit a new 52-week high on Friday after an insider bought additional shares in the company. The company traded as high as $66.49 and ...
Spire Wealth Management reduced its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.2% during the 1st quarter, according to the company in its most recent 13F filing with the ...
CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback